TY - JOUR AU - White, N. J. PY - 2005 DA - 2005// TI - Intermittent presumptive treatment for malaria. A better understanding of the pharmacodynamics will guide more rational policymaking JO - PLoS Medicine VL - 2 UR - https://doi.org/10.1371/journal.pmed.0020003 DO - 10.1371/journal.pmed.0020003 ID - White2005 ER - TY - JOUR AU - White, N. J. PY - 2002 DA - 2002// TI - The assessment of antimalarial drug efficacy JO - Trends Parasitol VL - 18 UR - https://doi.org/10.1016/S1471-4922(02)02373-5 DO - 10.1016/S1471-4922(02)02373-5 ID - White2002 ER - TY - JOUR AU - Watkins, W. M. AU - Mosobo, M. PY - 1993 DA - 1993// TI - Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life JO - Trans R Soc Trop Med Hyg VL - 87 UR - https://doi.org/10.1016/0035-9203(93)90431-O DO - 10.1016/0035-9203(93)90431-O ID - Watkins1993 ER - TY - JOUR AU - Hastings, I. AU - Watkins, W. M. AU - White, N. J. PY - 2002 DA - 2002// TI - Pharmacokinetic parameters affecting the evolution of drug-resistance in malaria. The role of the terminal elimination half-life JO - Philos Trans R Soc Lond B Biol Sci VL - 357 UR - https://doi.org/10.1098/rstb.2001.1036 DO - 10.1098/rstb.2001.1036 ID - Hastings2002 ER - TY - JOUR AU - Hastings, I. M. PY - 2004 DA - 2004// TI - The origins of antimalarial drug resistance JO - Trends Parasitol VL - 20 UR - https://doi.org/10.1016/j.pt.2004.08.006 DO - 10.1016/j.pt.2004.08.006 ID - Hastings2004 ER - TY - JOUR AU - ter Kuile, F. O. AU - van Eijk, A. M. AU - Filler, S. J. PY - 2007 DA - 2007// TI - Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy a systematic review JO - JAMA VL - 297 UR - https://doi.org/10.1001/jama.297.23.2603 DO - 10.1001/jama.297.23.2603 ID - ter Kuile2007 ER - TY - JOUR AU - Vallely, A. AU - Vallely, L. AU - Changalucha, J. AU - Greenwood, B. AU - Chandramohan, D. PY - 2007 DA - 2007// TI - Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed? JO - Malar J VL - 6 UR - https://doi.org/10.1186/1475-2875-6-16 DO - 10.1186/1475-2875-6-16 ID - Vallely2007 ER - TY - JOUR AU - Watkins, W. M. AU - Mberu, E. K. AU - Winstanley, P. A. AU - Plowe, C. PY - 1997 DA - 1997// TI - The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses JO - Parasitol Today VL - 13 UR - https://doi.org/10.1016/S0169-4758(97)01124-1 DO - 10.1016/S0169-4758(97)01124-1 ID - Watkins1997 ER - TY - JOUR AU - Simpson, J. A. AU - Aarons, L. AU - Collins, W. E. AU - Jeffery, G. AU - White, N. J. PY - 2002 DA - 2002// TI - Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection JO - Parasitology VL - 124 UR - https://doi.org/10.1017/S0031182001001202 DO - 10.1017/S0031182001001202 ID - Simpson2002 ER - TY - JOUR AU - Dietz, K. AU - Raddatz, G. AU - Molineaux, L. PY - 2006 DA - 2006// TI - Mathematical model of the first wave of Plasmodium falciparum asexual parasitemia in non-immune and vaccinated individuals JO - Am J Trop Med Hyg VL - 75 ID - Dietz2006 ER - TY - JOUR AU - Hastings, I. M. AU - Ward, S. A. PY - 2005 DA - 2005// TI - Coartem (artemether-lumefantrine) in Africa : the beginning of the end? JO - J Infect Dis VL - 192 UR - https://doi.org/10.1086/432554 DO - 10.1086/432554 ID - Hastings2005 ER - TY - JOUR AU - Baird, J. K. PY - 2004 DA - 2004// TI - Chloroquine resistance in Plasmodium vivax JO - Antimicrob Agents Chemother VL - 48 UR - https://doi.org/10.1128/AAC.48.11.4075-4083.2004 DO - 10.1128/AAC.48.11.4075-4083.2004 ID - Baird2004 ER - TY - JOUR AU - Hasugian, A. R. AU - Purba, H. L. AU - Kenangalem, E. AU - Wuwung, R. M. AU - Ebsworth, E. P. AU - Maristela, R. AU - Penttinen, P. M. AU - Laihad, F. AU - Anstey, N. M. AU - Tjitra, E. AU - Price, R. N. PY - 2007 DA - 2007// TI - Dihydroartemisinin-piperaquine versus artesunate-amodiaquine superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/512677 DO - 10.1086/512677 ID - Hasugian2007 ER - TY - JOUR AU - Menendez, C. AU - D'Alessandro, U. AU - ter Kuile, F. O. PY - 2007 DA - 2007// TI - Reducing the burden of malaria in pregnancy by preventive strategies JO - Lancet Infect Dis VL - 7 UR - https://doi.org/10.1016/S1473-3099(07)70024-5 DO - 10.1016/S1473-3099(07)70024-5 ID - Menendez2007 ER - TY - JOUR AU - Barnes, K. I. AU - Little, F. AU - Smith, P. J. AU - Evans, A. AU - Watkins, W. M. AU - White, N. J. PY - 2006 DA - 2006// TI - Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications JO - Clin Pharmacol Ther VL - 80 UR - https://doi.org/10.1016/j.clpt.2006.08.016 DO - 10.1016/j.clpt.2006.08.016 ID - Barnes2006 ER - TY - STD TI - Green MD, van Eijk AM, Kuile FO, Ayis J, Parise ME, Kager PA: Nahlen BL, Steketee R, Nettey H: Pharmacokinetics of sulfadoxine and pyrimethamine in HIV-infected and uninfected pregnant women in western Kenya. J Infect Dis. 196: 1403-8. 10.1086/522632. ID - ref16 ER - TY - STD TI - White NJ, Stepniewska K, Barnes K, Price RN, Simpson J: White NJ, Stepniewska K, Barnes K, Price RN, Simpson J. Simplified antimalarial therapeutic monitoring: using the Day 7 drug level?. Trends Parasitol. ID - ref17 ER - TY - JOUR AU - Talisuna, A. O. AU - Bloland, P. AU - D'Alessandro, U. PY - 2004 DA - 2004// TI - History, dynamics, and public health importance of malaria parasite resistance JO - Clin Microbiol Rev VL - 17 UR - https://doi.org/10.1128/CMR.17.1.235-254.2004 DO - 10.1128/CMR.17.1.235-254.2004 ID - Talisuna2004 ER -